Autolus Therapeutics PLC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Autolus Therapeutics has filed a registration statement for the resale of up to 54,584,250 American Depositary Shares (ADSs) by existing securityholders, including Blackstone and BioNTech.